Market Place
Sourcing Support
Candel Therapeutics Sees Prolonged Survival In (CAN-2409) Trial
17 Mar 2026 //
GLOBENEWSWIRE
Candel Therapeutics Reveals 2025 Financials And Corporate Updates
12 Mar 2026 //
GLOBENEWSWIRE
Candel Therapeutics To Unveil Extended Follow-Up Data
09 Mar 2026 //
GLOBENEWSWIRE
Candel Therapeutics to Present at TD Cowen Healthcare Conference
24 Feb 2026 //
GLOBENEWSWIRE
Candel Announces Proposed $100 Million Public Offering
19 Feb 2026 //
GLOBENEWSWIRE
Candel Therapeutics at 7th Annual GBM Drug Development Summit
11 Feb 2026 //
GLOBENEWSWIRE
Candel Therapeutics Grants Inducements Under Nasdaq 5635(c)(4)
02 Feb 2026 //
GLOBENEWSWIRE
Candel Therapeutics To Host Virtual R&D Event On December 5, 2025
17 Nov 2025 //
GLOBENEWSWIRE
Candel Therapeutics Reveals Q3 2025 Financials & Corporate Update
13 Nov 2025 //
GLOBENEWSWIRE
Century, Candel, Macrogenics Call Time On Trials To Save Cash
13 Nov 2025 //
FIERCE BIOTECH
Candel Therapeutics Appoints Immunology Expert Bali Pulendran
16 Oct 2025 //
GLOBENEWSWIRE
Candel Therapeutics Reports Positive Interim Data For CAN-3110
14 Oct 2025 //
GLOBENEWSWIRE
Candel Therapeutics To Present At The SITC 2025 Annual Meeting
03 Oct 2025 //
GLOBENEWSWIRE
Candel Therapeutics to Unveil CAN-2409 Phase 3 Results
17 Sep 2025 //
GLOBENEWSWIRE
Candel Boosts Russell Index Presence in 2025 Reconstitution
09 Jul 2025 //
GLOBENEWSWIRE
Candel Gets RMAT Designation For CAN-2409 In Prostate Cancer
28 May 2025 //
GLOBENEWSWIRE
Candel Therapeutics Reports Q1 2025 Financial Results
13 May 2025 //
GLOBENEWSWIRE
Candel Therapeutics Announces Publication of Phase 1b Trial Data
01 Apr 2025 //
GLOBENEWSWIRE
Candel Therapeutics Reports Prolonged Overall Survival in Phase 2
26 Mar 2025 //
GLOBENEWSWIRE
Candel Reports Positive Survival Data In Pancreatic Cancer
25 Feb 2025 //
GLOBENEWSWIRE
Candel`s cancer therapy meets late-stage trial goal
12 Dec 2024 //
REUTERS
C&el Therapeutics Presents Preclinical Data at SITC Annual Meeting
05 Nov 2024 //
GLOBENEWSWIRE
Kineta Announces KVA12123 Poster At SITC 2024
04 Oct 2024 //
GLOBENEWSWIRE
Biotech Innovations Surge as Global Cancer Diagnosis Rates Continue to Climb
09 May 2024 //
PR NEWSWIRE
Candel Announces Oral Presentation Update on Phase 1b Clinical Trial of CAN-3110
28 Mar 2024 //
GLOBENEWSWIRE
CAN-3110 Receives FDA Fast Track Designation
13 Feb 2024 //
GLOBENEWSWIRE
Candel Announces Nature Publication Showing Extended Survival with CAN-3110
18 Oct 2023 //
GLOBENEWSWIRE
Candel Announces New Data from Ongoing Phase 1 Clinical Trial of CAN-3110
19 May 2023 //
GLOBENEWSWIRE
